Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Jacobson Mark L.. Insider active across 1 company, notably Axsome Therapeutics, Inc.. Cumulatively, 18 filings have been recorded. Split: 0 buy · 7 sells. Total volume traded: €9.5m. History available since 1 April 2024. The latest transaction was filed on 3 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Jacobson Mark L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
10,000 shares@ US$12.95Common StockSEC:0001193125-26-382277:0
10,000 shares@ US$208.65Common StockSEC:0001193125-26-382277:1
4,517 shares@ US$12.950.0005% mcap1.3% of flowCommon StockSEC:0001193125-26-207148:0
4,517 shares@ US$227.940.0095% mcap23.2% of flowCommon StockSEC:0001193125-26-207148:1
233 shares@ US$12.950.0000% mcap0.1% of flowCommon StockSEC:0001193125-26-207148:2
233 shares@ US$228.180.0005% mcap1.2% of flowCommon StockSEC:0001193125-26-207148:3
35,378 shares@ US$2.851.9% of flowCommon StockSEC:0001193125-26-083586:0
10,000 shares@ US$2.850.6% of flowCommon StockSEC:0001193125-25-211788:0
5,783 shares@ US$116.1912.9% of flowCommon StockSEC:0001193125-25-206494:0
25,000 shares@ US$110.4463.7% of flowCommon StockSEC:0000950170-25-084556:1
25,000 shares@ US$8.024.6% of flowCommon StockSEC:0000950170-25-084556:0
20,673 shares@ US$6.471.4% of flowCommon StockSEC:0000950170-25-078552:0
20,673 shares@ US$104.6622.6% of flowCommon StockSEC:0000950170-25-078552:1
20,000 shares@ US$6.471.4% of flowCommon StockSEC:0000950170-25-078552:2
20,000 shares@ US$103.4521.8% of flowCommon StockSEC:0000950170-25-078552:3
47,739 shares@ US$4.044.7% of flowCommon StockSEC:0000950170-24-094967:0
13,693 shares@ US$1.300.4% of flowCommon StockSEC:0000950170-24-066177:0
24,662 shares@ US$1.300.8% of flowCommon StockSEC:0000950170-24-039617:0
About Jacobson Mark L.
Jacobson Mark L. is a declarant linked to Axsome Therapeutics, Inc., where the listed role is Chief Operating Officer. He has 16 filings in total, and across the sampled recent filings from 2024-04-01 to 2026-05-05, the activity is entirely sales, for a total of EUR 7658220, with Levée d'options as the most common transaction nature.